Great Point Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,495,500
| Closed | -$14.8M | – | 32 |
|
|
2024
Q2 | $14.8M | Hold |
1,495,500
| – | – | 2.84% | 16 |
|
|
2024
Q1 | $17.6M | Buy |
1,495,500
+215,000
| +17% | +$2.53M | 2.75% | 18 |
|
|
2023
Q4 | $18.2M | Buy |
1,280,500
+423,500
| +49% | +$6.01M | 3.1% | 15 |
|
|
2023
Q3 | $10.4M | Buy |
857,000
+155,608
| +22% | +$1.89M | 1.9% | 22 |
|
|
2023
Q2 | $8.81M | Buy |
701,392
+321,392
| +85% | +$4.04M | 1.72% | 22 |
|
|
2023
Q1 | $4.21M | Buy |
+380,000
| New | +$4.21M | 0.83% | 31 |
|
|
2021
Q4 | – | Sell |
-249,000
| Closed | -$2.38M | – | 40 |
|
|
2021
Q3 | $2.38M | Sell |
249,000
-1,351,000
| -84% | -$12.9M | 0.55% | 33 |
|
|
2021
Q2 | $15.4M | Buy |
+1,600,000
| New | +$15.4M | 3.24% | 11 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 34 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 35 |
|